Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
36005 POSTS 0 COMMENTS
People who are fit in their 40s seem to retain more brain volume two decades later and also perform better on decision-making tests

AHA: Midlife Fitness Equates to Better Cognition Decades Later

0
Tests show higher midlife fitness levels tied to greater brain volume, function decades later
Closely following the Mediterranean diet can significantly lower risk of heart disease

ACC: Mediterranean Diet Cuts Heart Disease Risk by About Half

0
People who followed it closely were 47 percent less likely to develop disease
High doses of omega-3 fatty acids may protect against further damage in myocardial infarction patients

ACC: High-Dose Omega-3 Protects Heart Following MI

0
Survivors who took large, daily dose of prescription-only capsules showed less decline in heart function
A vaccine for hepatitis E provides protection from the virus for at least 4.5 years

Vaccine May Provide Some Protection From Hepatitis E

0
Immunization offers nearly five years of protection, researchers say
One-third of Americans can't be transported by ambulance to a stroke center within one hour

One-Third of U.S. More Than Hour Away From Stroke Center

0
Lowest access found in southeastern United States, researchers say
For patients with breast cancer

Goserelin Protects Against Ovarian Failure in Breast Cancer

0
Randomized trial shows reduction in ovarian failure and more pregnancy for chemo + goserelin
Increased palliative care education and training among clinicians who are involved in cardiac critical care could benefit care

Study Examines Palliative Care in Cardiac Intensive Care Units

0
Patients who had end-of-life discussions had higher rate of redirected goals of care toward comfort care
Adults with eczema have a major health burden with significantly increased health care utilization and costs

Major Health, Cost Burden for U.S. Patients With Eczema

0
U.S. adults with eczema spent over $29 billion in out-of-pocket health costs in 2012
U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small-cell lung cancer

FDA: Opdivo Approval Expanded to Include Lung Cancer

0
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
For neonates with symptomatic congenital cytomegalovirus

Six Months of Valganciclovir in CMV Provides Long-Term Benefit

0
Improved hearing and developmental outcomes in long term for neonates with symptomatic CMV